Šimić, GoranLeko, Mirjana BabićWray, SelinaHarrington, Charles R.Delalle, IvanaJovanov-Milošević, NatašaBažadona, DaniraBuée, LucSilva, Rohan deGiovanni, Giuseppe DiWischik, Claude M.Hof, Patrick R.2017-04-122017-04-122017-04Šimić, G, Leko, M B, Wray, S, Harrington, C R, Delalle, I, Jovanov-Milošević, N, Bažadona, D, Buée, L, Silva, R D, Giovanni, G D, Wischik, C M & Hof, P R 2017, 'Monoaminergic Neuropathology in Alzheimer's disease', Progress in Neurobiology, vol. 151, pp. 101-138. https://doi.org/10.1016/j.pneurobio.2016.04.0010301-0082ORCID: /0000-0003-2250-3920/work/47672877http://hdl.handle.net/2164/8480Acknowledgments This work was supported by The Croatian Science Foundation grant. no. IP-2014-09-9730 (“Tau protein hyperphosphorylation, aggregation, and trans-synaptic transfer in Alzheimer’s disease: cerebrospinal fluid analysis and assessment of potential neuroprotective compounds”) and European Cooperation in Science and Technology (COST) Action CM1103 (“Stucture-based drug design for diagnosis and treatment of neurological diseases: dissecting and modulating complex function in the monoaminergic systems of the brain”). PRH is supported in part by NIH grant P50 AG005138.381639812eng5-hydroxytryptamine (serotonin)Alzheimer's diseaseamyloid beta (Aβ) peptideblood-brain barriercerebrospinal fluidepigeneticslocus coeruleusmetalsmonoaminesneurofibrillary degenerationnon-cognitive symptomsnucleus raphe dorsalisphosphorylationsleep-wake cycletau proteinRC0321 Neuroscience. Biological psychiatry. NeuropsychiatryRC0321Journal article10.1016/j.pneurobio.2016.04.001151